STATE-OF-THE-ART PAPER
Management of Heart Failure After Cardiac Resynchronization Therapy
Integrating Advanced Heart Failure Treatment With Optimal Device Function
Juan M. Aranda, Jr, MD, FACC*,*,
Gregory W. Woo, MD*,
Richard S. Schofield, MD, FACC*,
Eileen M. Handberg, ARNP, PhD*,
James A. Hill, MD, FACC*,
Anne B. Curtis, MD, FACC*,
Samuel F. Sears, PhD ,
J. Sean Goff, ARNP*,
Daniel F. Pauly, MD, FACC* and
Jamie B. Conti, MD, FACC*
* Division of Cardiovascular Medicine, College of Medicine, University of Florida Health Science Center, Gainesville, Florida
Department of Clinical and Health Psychology, College of Public Health and Health Professions, University of Florida Health Science Center, Gainesville, Florida.
Manuscript received December 22, 2004;
revised manuscript received February 23, 2005,
accepted March 10, 2005.
* Reprint requests and correspondence: Dr. Juan M. Aranda, Jr., 1600 SW Archer Road, Room M421, Gainesville, Florida 32610. (Email: arandjm{at}medicine.ufl.edu).
Cardiac resynchronization therapy (CRT) is an established adjunctive treatment for patients with systolic heart failure (HF) and ventricular dyssynchrony. The majority of recipients respond to CRT with improvements in quality of life, New York Heart Association functional class, 6-min walk test, and ventricular function. Management of HF after CRT may include up-titration of neurohormonal blockade and an exercise prescription through cardiac rehabilitation to further improve and sustain clinical outcomes. Diagnostic data provided by the CRT device may help to facilitate and optimize treatment. Initial nonresponder rates remain problematic. We suggest a simple step-by-step management and troubleshooting strategy that integrates device function with advanced HF therapy in patients who do not initially respond to CRT. This algorithm represents a new, comprehensive, collaborative approach between the HF and electrophysiology specialists to further improve and sustain outcomes in the field of CRT.
|
Abbreviations and Acronyms
| | AV = atrioventricular | | CRT = cardiac resynchronization therapy | | HF = heart failure | | LV = left ventricular | | NYHA = New York Heart Association | | VV = interventricular |
|
This article has been cited by other articles:

|
 |

|
 |
 
M. M. Borggrefe, T. Lawo, C. Butter, H. Schmidinger, M. Lunati, B. Pieske, A. R. Misier, A. Curnis, D. Bocker, A. Remppis, et al.
Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure
Eur. Heart J.,
April 2, 2008;
29(8):
1019 - 1028.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. T. Klodell Jr, J. M. Aranda Jr, D. C. McGiffin, B. K. Rayburn, B. Sun, W. T. Abraham, W. E. Pae Jr, J. P. Boehmer, H. Klein, and C. Huth
Worldwide surgical experience with the Paracor HeartNet cardiac restraint device
J. Thorac. Cardiovasc. Surg.,
January 1, 2008;
135(1):
188 - 195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Schoenfeld
Contemporary Pacemaker and Defibrillator Device Therapy: Challenges Confronting the General Cardiologist
Circulation,
February 6, 2007;
115(5):
638 - 653.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. T. Klodell Jr, D. C. McGiffin, B. K. Rayburn, B. Sun, W. T. Abraham, J. V. Conte, S. D. Russell, W. E. Pae Jr, J. P. Boehmer, and J. M. Aranda Jr
Initial United States experience with the Paracor HeartNet myocardial constraint device for heart failure
J. Thorac. Cardiovasc. Surg.,
January 1, 2007;
133(1):
204 - 209.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|